Publication Highlights
JUNE 2022
infection & immunobiology
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
december 2021
MS THERAPY
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in MS
October 2021
infection & immunobiology
COVID-19 vaccine response in people with multiple sclerosis
Summer 2021
Immunogenicity
Immunogenicity of biologics used in the treatment of moderate to severe psoriasis
summer 2021
immunogenicity
Immunogenicity of biologics used in the treatment of inflammatory bowel disease: A review
summer 2021
immunotherapy failure
Anti-drug antibodies to antibody-based therapeutics in multiple sclerosis